Skip to main content

Table 2 NTAb analytical specificity studies with interference

From: Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world

Interferent

Low concentration sample

High concentration sample

Neat

AU/mL

Spiked

AU/mL

Interfering bias, %

Neat

AU/mL

Spiked AU/mL

Interfering bias, %

Hemoglobin, 500 mg/dL

24.50

25.27

3.14

52.70

53.97

2.41

Conjugated bilirubin, 20 mg/dL

24.19

24.07

− 0.50

52.91

52.76

− 0.27

Triglyceride-rich lipid, 300 mg/dL

24.26

24.02

− 1.00

52.85

52.55

− 0.57